GLPwatch
The impact of preadmission/prediagnosis use of GLP-1 receptor agonists on COVID-19 mortality in patients with diabetes: A systematic review and meta-analysis.
Health Sci Rep · 2023
Last updated 2026-07-19| Journal | Health Sci Rep, 2023 |
|---|---|
| Citations | 3 |
| Relative citation ratio | 0.36 |
| NIH percentile | 22 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Full record and abstract on PubMed 37720167 ↗